The Discounted Cash Flow (DCF) valuation of Cosmo Pharmaceuticals NV (COPN.SW) is 100.10 CHF. With the latest stock price at 67.50 CHF, the upside of Cosmo Pharmaceuticals NV based on DCF is 48.3%.
Based on the latest price of 67.50 CHF and our DCF valuation, Cosmo Pharmaceuticals NV (COPN.SW) is a buy. buying COPN.SW stocks now will result in a potential gain of 48.3%.
| Range | Selected | |
| WACC / Discount Rate | 3.6% - 5.8% | 4.7% |
| Long-term Growth Rate | 1.0% - 3.0% | 2.0% |
| Fair Price | 59.06 - 435.58 | 100.10 |
| Upside | -12.5% - 545.3% | 48.3% |